Skip to main content
. 2017 Jul 12;91(15):e00672-17. doi: 10.1128/JVI.00672-17

TABLE 1.

NY/108 virus virulence in ferrets

Routea Doseb (EID50) No. of infected ferrets/total no.c % wt lossd Rise in tempe (°C) Peak titer in NWf No. of ferrets/total no.g:
No. of ferrets that seroconverted/total no.h
CW RS
i.n. 106 6/6 4.9 0.6 7.0 ± 0.8 (1–3) 1/6 0/6 6/6 (160–640)
AR 105.7 3/3 7.3 1.2 6.2 ± 0.6 (3–5) 0/3 2/3 3/3 (320–640)
AR 103.5 1/3 7.0 0.8 5.8 (5) 0/3 0/3 1/3 (320)
OA 102.9–103.6 2/3 8.0 0.9 6.0 ± 0.4 (7) 1/3 1/3 2/3 (160–320)
a

i.n., 1 ml liquid intranasal administration; AR, aerosol inhalation; OA, ocular aerosol exposure.

b

The specific aerosol dosing information is presented in the table in Fig. 2.

c

Number of ferrets with positive virus detection in nasal wash and seroconversion against homologous virus by the end of experiment/total number of ferrets tested.

d

Mean maximum weight loss observed among all infected ferrets through day 10 p.i.

e

Mean maximum rise in body temperature among all infected ferrets through day 10 p.i.

f

Mean maximum viral titer detected in nasal wash (NW) samples ± standard deviation. The day(s) of peak virus detection is specified in parentheses.

g

Number of ferrets with positive virus detection in conjunctival wash (CW) or rectal swab (RS) samples through day 5 p.i./total number of ferrets tested. The limits of virus detection were 100.8 EID50 and 101.5 EID50 for CW and RS samples, respectively.

h

Number of ferrets that seroconverted to homologous virus/total number of ferrets tested. The range of the hemagglutination inhibition titers is specified in parentheses.